During the first week of October, Mexico City will be the point of convergence of high-level discussions and exchanges focusing on systemic solutions for cancer care and control in Latin America.

The first United Nations (UN) High-level meeting on Universal Health Coverage (UHC) in New York ended with the adoption of a political declaration that represents a significant milestone for global health.

The fourth edition of the European Country 2 Country 4 Cancer (C2C4C) ride - which started on 9 September in Munich – came to an end with riders crossing the finish line at the Bristol-Myers Squibb (BMS) London office in Uxbridge.

Research on the causes, prevention and early detection of cancer is a key element in controlling the disease. This World Cancer Research day, UICC highlights the importance of collaboration.

Merck, a leading science and technology company and one of UICC’s Vanguard partners has released a new global report about women living with cancer.

Despite such support and meaningful progress being made to unite towards the common goal of reducing the global cancer burden and ensuring that it is top of the global agenda, this goal is still wrought with challenges.

UICC signed a new partnership agreement with CUBEBIO, a diagnostic and biomedical company from South Korea that focuses on the development of self-screening tests to detect cancer very early.